Cargando…

Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations

Third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) were developed to overcome EGFR T790M-mediated resistance to first- and second-generation EGFR-TKIs. Third-generation EGFR-TKIs, such as osimertinib and nazartinib, are effective for patients with the EGF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuzawa, Keita, Yasuda, Hiroyuki, Hamamoto, Junko, Nukaga, Shigenari, Hirano, Toshiyuki, Kawada, Ichiro, Naoki, Katsuhiko, Soejima, Kenzo, Betsuyaku, Tomoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739653/ https://www.ncbi.nlm.nih.gov/pubmed/29285266 http://dx.doi.org/10.18632/oncotarget.22297

Ejemplares similares

Non-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitors
por: Hamamoto, Junko, et al.
Publicado: (2017)

Secondary Brain Neoplasm after Stereotactic Radiosurgery in Patients with Metastatic Non-small Cell Lung Cancer
por: Nukaga, Shigenari, et al.
Publicado: (2018)

In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer
por: Hirano, Toshiyuki, et al.
Publicado: (2015)

EGFR-mutant Non-small Cell Lung Cancer Accompanied by Transient Asymptomatic Pulmonary Opacities Successfully Treated with “Stop-And-Go” Osimertinib
por: Kobayashi, Keigo, et al.
Publicado: (2017)

Intracellular levels of reactive oxygen species correlate with ABT‐263 sensitivity in non‐small‐cell lung cancer cells
por: Ohgino, Keiko, et al.
Publicado: (2020)

Comparison of detection methods of EGFR T790M mutations using plasma, serum, and tumor tissue in EGFR-TKI-resistant non-small cell lung cancer
por: Kobayashi, Keigo, et al.
Publicado: (2018)

Targeted Therapy-induced Facial Skin Toxicities: Impact on Quality of Life in Cancer Patients
por: Yagasaki, Kaori, et al.
Publicado: (2018)

Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinoma
por: Nishino, Makoto, et al.
Publicado: (2017)

A Case of Non-Small Cell Lung Cancer with Possible “Disease Flare” on Nivolumab Treatment
por: Chubachi, Shotaro, et al.
Publicado: (2016)

Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer
por: Tani, Tetsuo, et al.
Publicado: (2021)

Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer
por: SATO, TAKASHI, et al.
Publicado: (2015)

Multiple nodular lesions following Pneumocystis pneumonia in a non‐HIV immunocompromised patient
por: Asakura, Takanori, et al.
Publicado: (2016)

Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma
por: Hamamoto, Junko, et al.
Publicado: (2015)

Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells
por: Watanabe, Hideo, et al.
Publicado: (2008)

Sternoclavicular joint osteomyelitis extending to lung abscess complicated by Staphylococcal infective endocarditis
por: Masuzawa, Keita, et al.
Publicado: (2017)

Development of Necrotizing Myopathy Following Interstitial Lung Disease with Anti-signal Recognition Particle Antibody
por: Kusumoto, Tatsuya, et al.
Publicado: (2018)

Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports
por: Okamori, Satoshi, et al.
Publicado: (2017)

Trends of concerns from diagnosis in patients with advanced lung cancer and their family caregivers: A 2-year longitudinal study
por: Sato, Takashi, et al.
Publicado: (2021)

Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease
por: Chubachi, Shotaro, et al.
Publicado: (2017)

Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations
por: Ikemura, Shinnosuke, et al.
Publicado: (2019)

Liquid chromatography–tandem mass spectrometry metabolic profiling of nazartinib reveals the formation of unexpected reactive metabolites
por: Abdelhameed, Ali S., et al.
Publicado: (2019)

Spectroscopic and molecular docking studies reveal binding characteristics of nazartinib (EGF816) to human serum albumin
por: Almehizia, Abdulrahman A., et al.
Publicado: (2020)

Clinical efficacy and safety of nazartinib for epidermal growth factor receptor mutated non-small cell lung cancer: Study protocol for a prospective, multicenter, open-label
por: Cui, Jun, et al.
Publicado: (2021)

Dry pleurisy complicating solitary pulmonary nodules caused by Mycobacterium avium: a case report
por: Asakura, Takanori, et al.
Publicado: (2015)

Tuberous sclerosis diagnosed by incidental computed tomography findings of multifocal micronodular pneumocyte hyperplasia: a case report
por: Ishii, Makoto, et al.
Publicado: (2012)

Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung
por: Kuroda, Aoi, et al.
Publicado: (2017)

Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study
por: Ishikawa, Emi, et al.
Publicado: (2023)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

A case of skeletal tuberculosis and psoas abscess: disease activity evaluated using (18) F-fluorodeoxyglucose positron emission tomography-computed tomography
por: Kimizuka, Yoshifumi, et al.
Publicado: (2013)

DNA Methylation Profiles at Precancerous Stages Associated with Recurrence of Lung Adenocarcinoma
por: Sato, Takashi, et al.
Publicado: (2013)

Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study
por: Kakimi, Kazuhiro, et al.
Publicado: (2020)

Fatal Fulminant Pneumonia Caused by Methicillin-Sensitive Staphylococcus aureus Negative for Major High-Virulence Factors Following Influenza B Virus Infection
por: Masaki, Katsunori, et al.
Publicado: (2015)

Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2020)

Edoxaban treatment for pulmonary arterial thromboembolism associated with azygous vein aneurysm
por: Mochimaru, Takao, et al.
Publicado: (2017)

Disseminated histoplasmosis from a calcified lung nodule after long-term corticosteroid therapy in an elderly Japanese patient: A case report
por: Kobayashi, Keigo, et al.
Publicado: (2019)

Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease
por: Sato, Takashi, et al.
Publicado: (2014)

Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma
por: Takaoka, Hatsuyo, et al.
Publicado: (2022)

Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S
por: Lategahn, Jonas, et al.
Publicado: (2019)

Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (EGFR) Mutation with a History of Acquired Resistance to Osimertinib
por: Makimoto, Go, et al.
Publicado: (2019)

Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study)
por: Morikawa, Kei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2n289i6s9ajqd0s8ku43nade1p